Skip to content
Screener

Viatris VTRS Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

McKesson logo
McKessonMCK
$3.22B+61.6%
Cencora logo
CencoraCOR
$47.21B+67.6%
AMP
Amphastar PharmaceuticalsAMPH
$172K-98.2%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$134.67M
Merck & Co. logo
Merck & Co.MRK
$7.92B+780%
AbbVie logo
AbbVieABBV
$7.99B+100%

Other financials

Income statement

See full
Revenue$3.8B+4.9%
Gross profit$1.5B+9.3%
Operating income$6.3M-97.3%
Net income-$118.8M-2,483%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$890.0M+56.7%
Total debt$13.6B-7.7%
Total equity$14.3B-8.4%
Total assets$35.0B-8.8%

Cash flow

See full
Operating cash flow$381.8M+73.8%
CapEx$52.8M-0.2%
Free cash flow$329.0M+97.2%

Valuation

See full
Market cap$18.97B+84.7%
Enterprise value$31.71B+29.6%
P/S1.3×+0.6×

Profitability

See full
Gross margin34.8%-1.8pp
Operating margin-0.6%
Net margin-2.8%-1.3pp
FCF margin13.3%+0.9pp

Returns & leverage

See full
Return on equity-2.8%-1.3pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.

The source filing: Viatris’s 10-K, filed February 26, 2026.

Filed
Feb 26, 2026, 4:26 PM EST
Fiscal year
FY2025
Accession
0001792044-26-000013
Line itemYear Ended December 31, 2025Year Ended December 31, 2024Year Ended December 31, 2023
Proceeds from the sale of marketable securities23.926.026.3
Net cash (used in) provided by investing activities(427.7)1,800.7(864.5)
Cash flows from financing activities:
Proceeds from issuance of long-term debt0.3
Payments of long-term debt(0.1)(3,713.7)(1,250.2)
Payments of financing fees(1.5)(4.8)(0.5)
Change in short-term borrowings, net0.20.3
Purchase of common stock(500.5)(250.0)(250.0)

ITEM 8.Financial Statements And Supplementary Data

FAQ

What is Viatris's debt issuance proceeds?
Viatris (VTRS) reported debt issuance proceeds of $0 in Q4 2025.
What is the long-term trend for Viatris's debt issuance proceeds?
Over 4 years (2021 to 2025), Viatris's debt issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $1.71B to $0.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.

Ask your AI about Viatris's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude